AYUSH to dish out Rs 26 crore for quality control- Pharmaceuticals-Healthcare Biotech-News By Industry-News-The Economic Times
In an aspiration to make the complementary medicine manufacturing units to grow into Good Manufacturing Practices (GMP) compliant, Department of Ayurveda, Siddha, Unani and Homeopathy drugs (AYUSH) will be spending Rs 26 crore towards superiority control.
The department testament be funding for upgrading the existing community testing laboratories and and hand set up new inhouse quality curb labs championing GMP compliance using standards of USFDA or WHO guidelines, AYUSH's joint secretary Shiv Basant told PTI.
The Department initially allocated Rs 26 crore and whether the manufacturers change their mind-set to improve the standards and merit of their products to world standards, "we are ready to allocate more money," he said.
We have asked the manufacturing element to apply representing funds and the process is on. Depending on the response, we will definitely increase the allocation," he added. There are 8000 manufacturing constituent are in the country.
The department is also encouraging common testing labs for smaller Ayush manufacturing units where a swarm of 15 to 20 units can have a common quality containment labs and common facility for GMP compliance, he said.
Separate amount will also be drained on familiar facilities for raw stuff standardisation and quality control of finished products at situation having cluster of Ayush industries.
Three such clusteres are identified this year are at Nashik, Pune and Trissur, the seam secretary said. Contend this story with other readers. Click on 'Discuss' bond at the apex and backside of the story.
To know more about this facet click 'here'. Here is your fortune to get in touch with the best and brightest fiscal and business brains all over the world. Discuss' functionality in all its story pages.
This live chat feature that will qualify you to discuss any story with any other enticed reader sorrounding the world. All you need to do is click on the 'Discuss' link middle any story.
A colloquy window will pop open. You can enter any nickname or your real name in this chat window. To gaze who else is in the story discussion room, just click on the 'Visitors' link on the conversation window.
You can direct your exchange with other readers in the public domain where other readers too are free to join in or go into a private conversation mode.
ET Controversy Is FII beans returning to India?
From http://economictimes.indiatimes.com/news/news_by_industry/he~.cms